Johnson & Johnson COVID vaccine wins full approval in Canada in first major regulatory nod

- Advertisement -


Johnson & Johnson JNJ,
+0.62%
On Wednesday, its one-dose COVID-19 vaccine has been given full approval by Health Canada, its first major regulatory approval. The vaccine has been given an emergency use authorization in the US. So far, only the vaccine developed by Pfizer Inc. pfe,
-0.23%
and German partner BioNTech SE BNTX,
-4.00%
It has received full approval from the US regulator, the Food and Drug Administration, in an August decision. A full approval would allow the vaccine to be mandated by companies and institutions and experts hoped it would help convince unaffiliated people that the vaccine is safe and effective. “As vaccination rates continue to climb, a vaccine that prevents serious disease and prevents COVID-related hospitalization and death will help reduce the strain on health systems and help people in Canada and around the world.” An important option for us,” Mathai Maimon said. MD, PhD, global head, Janssen Research and Development, Johnson & Johnson, said in a statement. Shares of J&J were slightly lower than premarket, but are up 2% this year to date, while the Dow Jones Industrial Average (DJIA),
+0.55%
17% and the S&P 500 SPX,
+0.17%
25% increased.

- Advertisement -

,

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox